title: Exploitation of Interleukin-10 (IL-10) Signaling Pathways: Alternate Roles of Viral and Cellular IL-10 in Rhesus Cytomegalovirus Infection.
abstract: There is accumulating evidence that the viral interleukin-10 (vIL-10) ortholog of both human and rhesus cytomegalovirus (HCMV and RhCMV, respectively) suppresses the functionality of cell types that are critical to contain virus dissemination and help shape long-term immunity during the earliest virus-host interactions. In particular, exposure of macrophages, peripheral blood mononuclear cells, monocyte-derived dendritic cells, and plasmacytoid dendritic cells to vIL-10 suppresses multiple effector functions including, notably, those that link innate and adaptive immune responses. Further, vaccination of RhCMV-uninfected rhesus macaques with nonfunctional forms of RhCMV vIL-10 greatly restricted parameters of RhCMV infection following RhCMV challenge of the vaccinees. Vaccinees exhibited significantly reduced shedding of RhCMV in saliva and urine following RhCMV challenge compared to shedding in unvaccinated controls. Based on the evidence that vIL-10 is critical during acute infection, the role of vIL-10 during persistent infection was analyzed in rhesus macaques infected long term with RhCMV to determine whether postinfection vaccination against vIL-10 could change the virus-host balance. RhCMV-seropositive macaques, which shed RhCMV in saliva, were vaccinated with nonfunctional RhCMV vIL-10, and shedding levels of RhCMV in saliva were evaluated. Following robust increases in vIL-10-binding and vIL-10-neutralizing antibodies, shedding levels of RhCMV modestly declined, consistent with the interpretation that vIL-10 may play a functional role during persistent infection. However, a more significant association was observed between the levels of cellular IL-10 secreted in peripheral blood mononuclear cells exposed to RhCMV antigens and shedding of RhCMV in saliva. This result implies that RhCMV persistence is associated with the induction of cellular IL-10 receptor-mediated signaling pathways.
  
  
  OBJECTIVE
  Human health is adversely impacted by viruses that establish lifelong infections that are often accompanied with increased morbidity and mortality (e.g., infections with HIV, hepatitis C virus, or human cytomegalovirus). A longstanding but unfulfilled goal has been to develop postinfection vaccine strategies that could "reboot" the immune system of an infected individual in ways that would enable the infected host to develop immune responses that clear reservoirs of persistent virus infection, effectively curing the host of infection. This concept was evaluated in rhesus macaques infected long term with rhesus cytomegalovirus by repeatedly immunizing infected animals with nonfunctional versions of the rhesus cytomegalovirus-encoded viral interleukin-10 immune-modulating protein. Following vaccine-mediated boosting of antibody titers to viral interleukin-10, there was modest evidence for increased immunological control of the virus following vaccination. More significantly, data were also obtained that indicated that rhesus cytomegalovirus is able to persist due to upregulation of the cellular interleukin-10 signaling pathway.
authors: Center for Comparative Medicine, California National Primate Research Center, Department of Pathology and Laboratory Medicine, University of California, Davis, Davis, California, USA.
authors: Meghan K
authors: MK
authors: Eberhardt
authors: Department of Microbiology, University of Alabama at Birmingham, Birmingham, Alabama, USA.
authors: Ashlesha
authors: A
authors: Deshpande
authors: Center for Comparative Medicine, California National Primate Research Center, Department of Pathology and Laboratory Medicine, University of California, Davis, Davis, California, USA.
authors: Joseph
authors: J
authors: Fike
authors: Center for Comparative Medicine, California National Primate Research Center, Department of Pathology and Laboratory Medicine, University of California, Davis, Davis, California, USA.
authors: Rebecca
authors: R
authors: Short
authors: Center for Comparative Medicine, California National Primate Research Center, Department of Pathology and Laboratory Medicine, University of California, Davis, Davis, California, USA.
authors: Kimberli A
authors: KA
authors: Schmidt
authors: Department of Psychology, University of California, Davis, Davis, California, USA.
authors: Shelley A
authors: SA
authors: Blozis
authors: Department of Microbiology, University of Alabama at Birmingham, Birmingham, Alabama, USA walter@uab.edu pabarry@ucdavis.edu.
authors: Mark R
authors: MR
authors: Walter
authors: Center for Comparative Medicine, California National Primate Research Center, Department of Pathology and Laboratory Medicine, University of California, Davis, Davis, California, USA walter@uab.edu pabarry@ucdavis.edu.
authors: Peter A
authors: PA
authors: Barry
mesh_terms: D000818:Animals; D003587:Cytomegalovirus / Q000378:metabolism*; D003586:Cytomegalovirus Infections / Q000378:metabolism* / Q000821:virology*; D054884:Host-Pathogen Interactions / Q000502:physiology; D007117:Immunization, Secondary / Q000379:methods; D016753:Interleukin-10 / Q000378:metabolism*; D007963:Leukocytes, Mononuclear / Q000378:metabolism / Q000821:virology; D008253:Macaca mulatta / Q000378:metabolism* / Q000821:virology*; D015398:Signal Transduction / Q000502:physiology*; D014611:Vaccination / Q000379:methods; D014764:Viral Proteins / Q000378:metabolism; D017201:Virus Shedding / Q000502:physiology
chemical_list: D014764:Viral Proteins; D016753:Interleukin-10